Vicks survey: Consumers reluctant to take a sick day
CINCINNATI — As cold and flu stories continue to monopolize airwaves, a new study reports that people still look to power through with daily life when ill. According to the Centers for Disease Control and Prevention, a significant number of influenza cases have been reported in major cities nationwide, signaling the height of the national cold, cough and flu season. Despite healthcare providers’ counsel that sick patients should recover at home to help limit spreading the virus, a survey from the makers of Vicks NyQuil Severe and DayQuil Severe shows that under-the-weather consumers often struggle with whether or not to call in sick. The leading motive for deciding not to take a sick day, as reported by respondents, was work pressures (44.9%). Additional reasons, cited in the Fourth Annual Vicks Global Cold and Flu Survey, include financial concerns (42.5%) and fear of falling behind at the office (33.5%).
“While we were surprised to see just how many U.S. respondents were reluctant to call in sick when experiencing a cold or flu, at Vicks, we understand that sometimes you just can’t take a sick day,” stated Dave Tomasi, Vicks North American marketing director. “As a brand, Vicks offers multiple solutions, such as NyQuil Severe and DayQuil Severe to help you feel better fast — whether you’re taking the day to recoup or you still need to put dinner on the table for the family.”
IMS Health Flu Activation Network, which measures the number of Influenza Like Illness incidents nationwide, recently released data showing elevated flu activity in all parts of the country, even though flu season historically hasn't peaked in the United States until late January or February.
Across the South Atlantic, IMS Health reported 10.1 million cases of ILI, up 21.4% as compared to last week. ILI in the Mid-Atlantic region totaled 6.9 million, up 27.1%, and across the Pacific at 6.4 million, up 28.4%.
“The influenza virus circulating this year has mutated, and federal officials have warned that this year's vaccine may not provide as much protection — this has a lot of people very nervous,” stated Vicks spokesperson Barb Dehn. “I recommend that sick patients get plenty of rest at home, if they can, to limit the spread of the virus. As always, consult with your healthcare provider. If you simply cannot take a sick day, there are effective over-the-counter medications on the market today to help you power through your cold and flu symptoms.”
The Fourth Annual Vicks Global Cold and Flu Survey was conducted by Survey Monkey in two waves between April and July of 2014, at the end of the cold, cough and flu seasons across 15 nominated markets. One thousand interviews were fielded in 15 countries each using an online questionnaire. The 15 markets surveyed include the United States, Germany, France, Spain, Italy, Russia, Poland, Ukraine, Hungary, India, Indonesia, China, Mexico, Australia and Brazil.
One-in-10 patients receive inappropriate aspirin therapy for primary prevention of cardiovascular disease
NEW YORK — More than 1-in-10 patients within the National Cardiovascular Disease Registry’s Practice Innovation and Clinical Excellence registry were receiving inappropriate aspirin therapy for primary prevention of cardiovascular disease, according to a new study published in the Journal of the American College of Cardiology by a team at Baylor College of Medicine in Texas.
According to the research, the risks of gastrointestinal bleeding and hemorrhagic strokes associated with aspirin use outweigh any potential protective benefit. According to the guidelines on primary prevention of CVD, aspirin use is considered appropriate only in patients with 10-year CVD risk of greater than 6%.
"Aspirin use is recommended for secondary prevention of patients with pre-existing cardiovascular disease," commented Valentin Fuster, JACC editor-in-chief. "Additionally, aspirin is recommended for primary prevention in patients without cardiovascular disease who have moderate to high 10-year risk of developing cardiovascular disease," he said. "In those individuals in whom the 10-year cardiovascular disease risk was less than 6% … aspirin should not be indicated."
The Food and Drug Administration recently issued a public advisory against the general use of aspirin for primary prevention of heart attacks and strokes, researchers noted. "We have to be concerned with primary prevention but not necesarily by using aspirin indiscriminately," Fuster said. "Avoid the inappropriate use of aspirin, which in my view … occurs in more than 12% of individuals in this country, if we look at those who seek medical consultation in order to prevent heart attacks and strokes."
University of Florida’s Pharm.D. program highlights risks associated with APAP
GAINESVILLE, Fla. — The University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use.
Acetaminophen is one of the most widely used over-the-counter drugs for pain relief, but it has been at the center of debate over its safety as overdoses and misuses are being linked to a number of serious health issues, the university noted. For instance, there is a 123% increase in the risk of kidney disease when acetaminophen is combined with a small-to-moderate amount of alcohol, and taking as few as 4-to-5 extra strength pills over the course of 24 hours can cause liver damage.
More than 600 medications contain acetaminophen, including those that are over-the-counter and by prescription only. Individuals who take several medications a day should take care to note if there is acetaminophen contained in each one, and how much there is in the medication. It can be easy to take too much, which is considered to be over 4,000 mg per day, according to the Food and Drug Administration.
Source: University of Florida's Pharm.D. program
Loading Post Please Wait...